Ahead of earnings announcement, shares of Aurobindo Pharma ended the trading session flat at ₹1,184.50 apiece on the BSE, down 0.62%.
Aurobindo Pharma Q3 Results: Revenue beats estimates, profit and margin under pressure
Share it
Open an Account in less than 1 Min.
Need help? Call us
+91 976 976 8500
Services
Company
Get in touch
- +91 976 976 8500
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade